SCHEMBL312223

SCHEMBL312223

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2ccc(O)cc2o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.56
HPGD P15428 7/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TP53 P04637 2/20 0.50
ALOX15 P16050 1/20 0.50
KDM4E B2RXH2 5/20 0.49
HSD17B10 Q99714 4/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 4/20 0.48
ALDH1A1 P00352 4/20 0.48
QPCT Q16769 3/20 0.48
CYP19A1 P11511 2/20 0.48
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
MPO P05164 1/20 0.48
MAPK1 P28482 1/20 0.48
IP6K2 Q9UHH9 1/20 0.48
CYP2C9 P11712 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311784 0.91 AKR1B1 (0.46) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL324201 0.91 HPGD (0.61) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL311791 0.91 HPGD (0.51) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL311364 0.88 HPGD (0.44) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL311620 0.88 AKR1B1 (0.43) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312841 0.88 AKR1B1 (0.50) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312477 0.86 BACE1 (0.61) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312060 0.86 HPGD (0.44) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312670 0.86 HPGD (0.42) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL311355 0.84 AKR1B1 (0.51) AKR1B1HPGDMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed